Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial.
AIMS: Few smokers who try to quit smoking use smoking cessation treatment (SCT), and cost could be one factor. To increase the number of successful quitters, we assessed whether financial reimbursement for SCT would encourage the use of SCT and would as a result increase the 6-month point abstinence...
| Published in: | Addiction Vol. 100; no. 7; pp. 1012 - 1021 |
|---|---|
| Main Authors: | , , , |
| Format: | clinical trial research tables/charts Journal Article |
| Published: |
Wiley-Blackwell
Jul2005
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106493333&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106493333 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09652140 AIO jtl: Addiction issn: 09652140 maglogo: Y pubinfo: dt: Jul2005 vid: 100 iid: 7 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 106493333 106493333 2005114970 10.1111/j.1360-0443.2005.01097.x NLM15955017 106493333 ppf: 1012 ppct: 9 formats: fmt: @attributes: type: P tig: atl: Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. aug: au: Kaper J Wagena EJ Willemsen MC van Schayck CP affil: Department of General Practice, Care and Public Health Research Institute (CAPHRI), Maastricht University, PO Box 616, 6200 MD Maastricht the Netherlands; janneke.kaper@hag.unimaas.nl sug: subj: Smoking Cessation Adult Bupropion Clinical Trials Confidence Intervals Control Group Experimental Studies Female Funding Source Male Middle Age Netherlands Nicotine Replacement Therapy Odds Ratio Questionnaires Random Assignment Random Sample Human Adult: 19-44 years Middle Aged: 45-64 years Female Male ab: AIMS: Few smokers who try to quit smoking use smoking cessation treatment (SCT), and cost could be one factor. To increase the number of successful quitters, we assessed whether financial reimbursement for SCT would encourage the use of SCT and would as a result increase the 6-month point abstinence rate. SETTING AND PARTICIPANTS: We recruited smokers aged over 18 years from a random sample of Dutch inhabitants insured by one health insurance company. INTERVENTION AND DESIGN: The smokers were assigned randomly to the intervention group (n = 632) or control group (n = 634). Respondents in the intervention group received an offer of reimbursement for nicotine replacement therapy, bupropion and behavioural counselling. No reimbursement was offered to the control group. To preclude a change of behaviour due to disappointment in the control group, we used a randomized consent design. FINDINGS: During the reimbursement period, 10.8% smokers in the intervention group reported having used SCT compared with 4.1% in the control group (OR = 2.9, 95% CI 1.8-4.7). In the intervention group, 23.4% smokers tried to stop compared with 20.8% in the control group (OR = 1.2, 95% CI 0.9-2.4). After 6 months, the biochemically validated 7-day point prevalence abstinence rate was 5.5% in the intervention group and 2.8% in the control group (OR = 2.3, 95% CI 1.2-4.1). CONCLUSIONS: Reimbursement for SCT seems efficacious in increasing the use of SCT and may double the number of successful quitters. pubtype: Academic Journal doctype: clinical trial research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|